|
703 Locums vote with their feet over poor conditions Locum pharmacists are reluctant to report poor practice and are more likely to vote with their feet by not returning to that pharmacy
...more
703 PPRS will cut pharmacy profits as well as save money for the NHS Community pharmacies will suffer reduced profits when the renegotiated Pharmaceutical Price Regulation Scheme takes effect at the start of next year ...more
703 Agenda
for Change on brink of acceptance General acceptance of the
Agenda for Change NHS pay and conditions review package is looking increasingly
likely now that most members of Unison, the UK's largest trade union
representing 1.3 million workers, have said they are happy with it ...more
704 Vioxx
"should have been withdrawn four years ago" Merck had sufficient data to justify withdrawing Vioxx (rofecoxib) four years ago, a study published online by The Lancet claims ...more
704 Government’s
response on scientific publishing disappoints MPs Members
of the House of Commons Science and Technology Select Committee have
been disappointed by the Government's response to their recommendations
on scientific publishing. ...more
704 MHRA rejects alleged advertising breaches Two recent newspaper reports and a television advertisement did not break the rules on advertising medicines, the Medicines and Healthcare products Regulatory Agency has decided
...more
704 Halve MRSA infection rates Rates of bacteraemia caused by methicillin resistant Staphylococcus
aureus in NHS hospitals should be halved by March 2008, Health Secretary, John Reid has announced
...more
705 Welsh funding for new contract will match English The Welsh Assembly Government has reaffirmed its view that the new pharmacy contract applies to both England and Wales, and has announced that it will match the funding provision for England
...more
705 PSNC warns pharmacy contractors to get their sums right Pharmacy contractors have been warned by the Pharmaceutical Services Negotiating Committee not to be misled over the level of income they will receive under the proposed new pharmacy contract
...more
705 Health screening takes off in Pembrokeshire Nine community pharmacies in Pembrokeshire are taking part in the roll out of a health-screening scheme in conjunction with GPs and diet and exercise advisers
...more
705 Welsh substance misuse framework launched Guidelines on the treatment of substance misuse were published by the Welsh Assembly Government last week
...more
706 ACE inhibitors not needed in stable heart disease Patients with stable heart disease who are
already receiving standard therapy are not likely to benefit from additional treatment with angiotensin-converting enzyme inhibitors, results from a new study indicate
...more
706 Effectiveness of atenolol for patients with hypertension questioned Concerns about the effectiveness of atenolol in preventing deaths from strokes and heart disease in patients with hypertension have been raised in a recent study
...more
706 Combination heart failure therapy effective in black patients Adding isosorbide dinitrate and hydralazine to conventional therapy for heart failure reduces relative one-year mortality by 43 per cent among black people, a new study has shown
...more
706 Pneumonia and
ulcer drugs Use of medicines that suppress gastric acid is associated
with an increased risk of community-acquired pneumonia ...more
706 Hypertension
in black people The effectiveness of antihypertensive drugs in
black people is the topic of the latest issue of Effective Health Care, produced
by the Centre for Reviews and Dissemination at The University of York ...more
|
707 New prescribers may be susceptible to promotion Supplementary prescribing may make
pharmacists more susceptible to promotional pressure from pharmaceutical companies and additional training may be needed to counter this
...more
707 Call for full allergy service from pharmacists Community pharmacists could help plug a major gap in NHS services for allergy patients, according to Allergy UK
...more
707 Drug safety helps win £1m Steps taken to reduce drug-related patient safety incidents in a number of hospitals have helped them win £1m awards to improve patient safety further
...more
707 Food supplement law is likely to come under pressure European law on food supplements is likely to come under pressure as a result of an international agreement on maximum amounts of vitamins and minerals in food supplements
...more
707 MedicinesComplete MedicinesComplete, published by the Pharmaceutical Press, has been shortlisted for best science, technology and medicine information product at the International Information Industry Awards ...more
708 Oral chemotherapy can save time and money Treating colorectal cancer patients after surgery with the oral chemotherapy agent capecitabine (Xeloda) rather than intravenous
5-fluorouracil/leucovorin (IV 5-FU/LV) saves hospital time equivalent to gaining an additional pharmacist, suggest researchers ...more
708 Erythropoietin may reduce cancer progression Patients with cancer-related anaemia treated with epoetin beta (NeoRecormon) show a trend to reduced risk of tumour progression, according to a meta-analysis reported at the European Society for Medical Oncology conference in Vienna last week
...more
708 CPPE relaunches e-learning Pharmacists who need to update their knowledge can now use a redesigned
e-learning portal to access online courses from the Centre for Pharmacy Postgraduate Education
...more
708 Pharmacist wins “Leaders for change” award Faranak Ansari, pharmacist and quality improvement co-ordinator at Dundee University faculty of medicine, dentistry and nursing, has received a “Leaders for change” award from the charity The Health Foundation ...more
R&D
709 Technology could cut costs of vaccination programmes New “stable liquid” technology could provide significant savings in the costs of immunisation programmes by removing the need for vaccines to be refrigerated ...more
709 Novel therapies for breast cancer and infections in GSK’s pipeline Novel therapies to treat breast cancer, HIV and hepatitis B infections are generating encouraging results for GlaxoSmithKline ...more
709 New technique for switching off genes can reduce cholesterol levels in mice Use of a technique called RNA interference (RNAi) to switch off a gene encoding apolipoprotein B (apoB) reduces cholesterol levels in mice, a recent study has shown ...more
709 First glycylcycline antibiotic shows promise as treatment for abdominal infections Tigecycline, the first in a new antibiotic class — the glycylcyclines — is showing promise as a treatment for abdominal infections ...more
709 Trial shows malaria vaccine for young children is effective A vaccine against malaria for young children is feasible, a trial in Mozambique has shown ...more
|
The
Pharmaceutical Journal